Stockscreener 앱 받기
0.801
3.62%
0.028
시간 외 거래:
.81
0.009
+1.12%
전일 마감가:
$0.773
열려 있는:
$0.7926
하루 거래량:
1.62M
Relative Volume:
0.82
시가총액:
$127.08M
수익:
$3,000
순이익/손실:
$-108.00M
주가수익비율:
-0.5336
EPS:
-1.501
순현금흐름:
$-87.84M
1주 성능:
+2.59%
1개월 성능:
+7.81%
6개월 성능:
-62.22%
1년 성능:
-58.28%
1일 변동 폭
$0.7524
$0.8199
1주일 범위
$0.73
$0.8199
52주 변동 폭
$0.3772
$2.445
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.801 | 122.64M | 3,000 | -108.00M | -87.84M | -1.501 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-15 | 개시 | H.C. Wainwright | Buy |
| 2025-08-28 | 개시 | Ladenburg Thalmann | Buy |
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
모두보기
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Fractyl Health Inc (GUTS) Cash Flow - TradingKey
Fractyl Health Inc (GUTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Fractyl Health Market Sentiment - Benzinga España
GUTS|Fractyl Health Inc|Price:0.773|Chg%:+0.016 - TradingKey
Enterprise value to revenue forward of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Fractyl Health Inc (GUTS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fractyl Health CEO to present at key biotech investor conferences in July and August 2026 - Pluang
Fractyl Health CEO to Join Meetings and Aug. 12 Fireside Chat - Stock Titan
Fractyl Health stock up on encouraging one-year Revita study results - MSN
Fractyl Health helps maintain weight after stopping popular obesity drugs, stock soars - MSN
Fractyl Health (GUTS) AGM 2026 Summary - Quartr
Fractyl Health (GUTS) Morgan Stanley 22nd Annual Global Healthcare Conference summary - Quartr
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Fractyl Health, Inc. (GUTS) - The Globe and Mail
Price to sales forward of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Morgan Stanley Maintains Fractyl Health(GUTS.US) With Hold Rating, Maintains Target Price $2 - Moomoo
CCORF Maintains Fractyl Health(GUTS.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Craig-Hallum Maintains Fractyl Health(GUTS.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: Fractyl Health, Inc. (GUTS), AbbVie (ABBV) - The Globe and Mail
Fractyl Health Stock Up on Encouraging One-Year Revita Study Results - Yahoo Finance
Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation - Sahm
Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock Soars - Sahm
Fractyl Health reports positive randomized data from REMAIN-1 Midpoint Cohort demonstrating durable weight maintenance one year after GLP-1 discontinuation - News-Medical
H.C. Wainwright reiterates Buy on Fractyl Health stock at $8 - Investing.com UK
H.C. Wainwright reiterates Buy on Fractyl Health stock at $8 By Investing.com - Investing.com South Africa
Fractyl Health reports one-year data from weight maintenance trial - Investing.com UK
Morgan Stanley reiterates Fractyl Health stock rating on weight maintenance data - Investing.com
Fractyl Health’s Revita Procedure Shows 84% Weight Loss Maintenance One Year After GLP-1 Discontinuation in REMAIN-1 Study – Minichart - Minichart
Fractyl gains after data for Revita procedure (GUTS:NASDAQ) - Seeking Alpha
Fractyl reports 7.8 percent weight regain with Revita - grafa.com
Fractyl Health reports one-year data from weight maintenance trial By Investing.com - Investing.com South Africa
GUTS: Revita maintains up to 84% of GLP-1-induced weight loss at one year with strong safety - TradingView
Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
GUTS: Revita enabled up to 84% weight loss retention one year after GLP-1 discontinuation - TradingView
Fractyl Health (Nasdaq: GUTS) reports 1-year Revita weight maintenance data - Stock Titan
Fractyl Health Reports Positive Randomized Data from - GlobeNewswire
Price to book forward of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Number of shareholders of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Fractyl Health (GUTS) Slides 3.9% as Biotech Stock Tests Support Near $0.72Force Index - dars.gov.et
Fractyl Health (GUTS) Slides 3.9% as Shares Approach Critical Support at $0.72Ichimoku Cloud - dars.gov.et
Fractyl Health (GUTS) Stock Sees Fair Value Cut As Analysts Weigh Revita Opportunity - Yahoo Finance
Fractyl Health (GUTS) Q1 2026 Earnings: Wider-than-Expected Loss, No Revenue, Shares SlipEarnings Manipulation Risk - dars.gov.et
Fractyl Health (GUTS) Tests Support Near $0.76 as Downside Pressure PersistsDealer Delta - dars.gov.et
GUTSFractyl Health Inc Options - Finviz
Fractyl Health Price Target Announced at $4.00/Share by Craig-Hallum - Moomoo
GUTS Initiates Coverage by Fractyl Health -- Price Target Set at $4.00 - GuruFocus
Fractyl Health Initiated at Buy by Craig-Hallum - Moomoo
Craig-Hallum initiates Fractyl Health stock coverage with buy rating By Investing.com - Investing.com India
Craig-Hallum initiates Fractyl Health stock coverage with buy rating - Investing.com
Craig-Hallum Initiates Fractyl Health at Buy With $4 Price Target - Moomoo
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):